Related Research Articles
Hala Moddelmog became the first female president and CEO of the Metro Atlanta Chamber (MAC) in January 2014 following a career in the corporate and non-profit sectors. Moddelmog has 19 years of career experience in president and CEO roles. Her areas of expertise are strategic planning, marketing, brand and product development, and assembling and managing high performance teams and brand revitalization.
Susan G. Komen, formerly known as Susan G. Komen for the Cure and originally as The Susan G. Komen Breast Cancer Foundation, often referred to as simply Komen, is the largest and best-funded breast cancer organization in the United States.
Nancy Goodman Brinker is the founder of The Promise Fund and Susan G. Komen, an organization named after her only sister, Susan, who died from breast cancer in 1980 at age 36. Brinker was also United States Ambassador to Hungary from 2001 to 2003 and Chief of Protocol of the United States from 2007 to the end of the George W. Bush administration. Brinker, a breast cancer survivor, uses her experience to heighten understanding of the disease. She speaks publicly on the importance of patient's rights and medical advancements in breast cancer research and treatment. She is currently serving as the World Health Organization's Goodwill Ambassador for Cancer Control. Brinker is the author of the New York Times bestselling book Promise Me - How a Sister's Love Launched the Global Movement to End Breast Cancer, released on September 14, 2010.
The Komen Brinker Award for Scientific Distinction was established by Susan G. Komen for the Cure in 1992 to recognize leading scientists for their significant work in advancing research concepts or clinical application in the fields of breast cancer research, screening or treatment.
The mission of the Madison, Wisconsin-based International Breast Cancer Research Foundation (IBCRF) (1993–2015) was to pursue cost-effective, clinical research with the aim of alleviating the difficult circumstances of women throughout the world. Peer-reviewed research at the organization was generously funded by the National Institutes of Health, The Susan G. Komen Foundation, and the Breast Cancer Research Foundation.
The Triple Negative Breast Cancer Foundation is a nonprofit organization dedicated to raising awareness of triple-negative breast cancer. The foundation supports scientists and researchers in their efforts to determine the definitive causes of triple-negative breast cancer so that effective detection, diagnosis, prevention, and treatment can be pursued and achieved.
Edison T. Liu, M.D., is the president and CEO of The Jackson Laboratory, and was the president of Human Genome Organization, HUGO from 2007-2013.
John E. Niederhuber, MD was the 13th director of the National Cancer Institute (NCI), from 2006 until July, 2010, succeeding Andrew von Eschenbach, who went on to become a director at biotechnology firm BioTime. A nationally renowned surgeon and researcher, Dr. Niederhuber has dedicated his four-decade career to the treatment and study of cancer - as a professor, cancer center director, National Cancer Advisory Board chair, external advisor to the NCI, grant reviewer, and laboratory investigator supported by NCI and the National Institutes of Health. He is now Executive Vice President/CEO Inova Translational Medicine Institute and Inova Health System and Co-Director, Johns Hopkins Clinical Research Network.
Alexine Clement Jackson was the Chair, Board of Directors of Susan G. Komen and former National President of the Young Women's Christian Association (YWCA). She is the immediate past president of Black Women's Agenda and former Chair, the National Museum of Women in the Arts.
Eric P. Winer is chief of the Division of Women's Cancers and director of the Breast Oncology Program in the Susan F. Smith Center for Women's Cancers at Dana-Farber Cancer Institute in Boston, Massachusetts. He also serves as the Institute's chief strategy officer. He is the Thompson Senior Investigator in Breast Cancer Research and a Professor of Medicine at Harvard Medical School. Winer is a medical oncologist and clinical researcher specializing in breast cancer. He has focused his career on treating patients with breast cancer and advancing understanding of the disease. He is committed to delivering the best care to his patients today while striving to improve the methods of care for the future.
Edith A. Perez, M.D., is a world-renowned American translational researcher and cancer specialist, known equally for her impact in designing innovative clinical trials and for her patient-centered humanitarian passion.
Kay Dickersin is an academic who trained first in cell biology and subsequently epidemiology. She went on to a career studying factors that influence research integrity, in particular publication bias and outcome reporting bias. She is retired Professor Emerita in the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health where she was Director of the Center for Clinical Trials and Evidence Synthesis there. She was also Director of the US Cochrane Center and the US Satellite of the Cochrane Eyes and Vision Group within the Cochrane Collaboration. Dickersin received multiple awards for her research.
William G. Kaelin Jr. is an American Nobel Laureate physician-scientist. He is a professor of medicine at Harvard University and the Dana-Farber Cancer Institute. His laboratory studies tumor suppressor proteins. In 2016, Kaelin received the Albert Lasker Award for Basic Medical Research and the AACR Princess Takamatsu Award. He also won the Nobel Prize in Physiology or Medicine in 2019 along with Peter J. Ratcliffe and Gregg L. Semenza.
Blossom Damania is a virologist at the University of North Carolina at Chapel Hill. She is known for her work on oncogenic viruses that cause human cancer.
Fiona Jane Gilbert is a Scottish radiologist and academic.
Elizabeth M. Jaffee is an American oncologist specializing in pancreatic cancer and immunotherapy.
Elisa Rush Port FACS is Associate Professor of Surgery at the Icahn School of Medicine at Mount Sinai Hospital, as well as cofounder and director of the Dubin Breast Center at the Tisch Cancer Institute at Mount Sinai Health System, since 2010. She has received four research grants, has served as an investigator or co-investigator on 15 clinical trials, published 44 peer-reviewed articles, and published a total of 12 book chapters and books. She has specialized in sentinel-node biopsy, a diagnostic method that determines cancer stages based on spread to regional lymph nodes, nipple sparing mastectomy, and the use of MRI for breast cancer.
Susan M. Domchek is an oncologist at the University of Pennsylvania. She has authored more than 250 articles in scholarly journals and serves on a number of editorial review boards. In 2018, Domchek was elected to the National Academy of Medicine.
Bettina Meiser is a professor at the University of New South Wales, with expertise in the psychosocial aspects of genetics; cancer, hereditary cancer, and the impact of genetic counselling and testing.
Wendy Rosamund Brewster is a Professor of Obstetrics and Gynaecology and Director of the Center for Women's Health Research at the University of North Carolina at Chapel Hill.
References
- ↑ Brinker, Nancy; Braun, Susan (1998-12-01). "The Susan G. Komen Breast Cancer Foundation1". Breast Disease. 10 (5–6): 23–28. doi:10.3233/bd-1998-105-604. ISSN 1558-1551. PMC 1508105 . PMID 10935494.
- 1 2 "BCBSNC Names Dr. Lisa Carey to Board of Trustees". mediacenter.bcbsnc.com. May 22, 2012. Retrieved April 5, 2019.
- ↑ "Lisa A. Carey". UNC Lineberger. Retrieved 2019-04-05.
- ↑ Adams, Jill U. (2007-11-23). "Interdisciplinary Research: Building Bridges, Finding Solutions". Science. doi:10.1126/science.opms.r0700032. ISSN 1095-9203.
- ↑ "Lisa Carey is Appointed to Susan G. Komen's Scientific Advisory Board". med.unc.edu. Retrieved April 5, 2019.